Conversely, WT tumor cells showed leading proliferation-promoting TFs (E2F4 and ETV4), aligning with rapid cell cycle advancement and glycolytic reprogramming [48–50] (Fig. 2H). The gene discussed is E2F4; the disease is neoplasm.